The companies are in advanced talks on an all-stock deal that would hand IPXL shareholders 25% of a new publicly traded company and owners of closely-held Amneal the remainder, according to the report.
On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all outstanding shares of IPXL in a stock-for-stock transaction. WeissLaw is investigating whether IPXL's Board acted to …
NBC 21mon
Impax Laboratories Inc. (IPXL) announced after the bell Monday that it has received approval from the FDA for a generic version of Renvela tablets, 800 mg. The stock is now up 1.05 on 34K shares. Impax Laboratories gapped down slightly …
Impax Laboratories Inc. IPXL, -4.24% shares rose 4.4% in premarket trade Tuesday after the company said that its generic Renvela, used to lower phosphorus levels for patients on kidney dialysis, had been approved by the Food and …
On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all outstanding shares of IPXL in a stock-for-stock transaction. WeissLaw is investigating whether IPXL's Board acted to …
On October 17, 2017, the Company announced that it had reached a definitive agreement for Amneal to acquire all outstanding shares of IPXL in a stock-for-stock transaction. WeissLaw is investigating whether IPXL's Board acted to …